Medico Remedies Limited (MEDICO.NS)
- Previous Close
54.50 - Open
54.95 - Bid --
- Ask --
- Day's Range
51.23 - 54.95 - 52 Week Range
34.80 - 79.83 - Volume
418,413 - Avg. Volume
1,313,356 - Market Cap (intraday)
4.523B - Beta (5Y Monthly) --
- PE Ratio (TTM)
49.87 - EPS (TTM)
1.06 - Earnings Date Aug 11, 2025 - Aug 15, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations. It exports its products. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.
medicoremedies.com--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: MEDICO.NS
View MorePerformance Overview: MEDICO.NS
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MEDICO.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MEDICO.NS
View MoreValuation Measures
Market Cap
4.42B
Enterprise Value
4.52B
Trailing P/E
49.87
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.96
Price/Book (mrq)
7.90
Enterprise Value/Revenue
3.02
Enterprise Value/EBITDA
28.61
Financial Highlights
Profitability and Income Statement
Profit Margin
6.57%
Return on Assets (ttm)
8.48%
Return on Equity (ttm)
17.58%
Revenue (ttm)
1.54B
Net Income Avi to Common (ttm)
100.93M
Diluted EPS (ttm)
1.06
Balance Sheet and Cash Flow
Total Cash (mrq)
25.45M
Total Debt/Equity (mrq)
23.53%
Levered Free Cash Flow (ttm)
-66.28M